InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
-0.41%
)
US TECH 100
19,181.60
(
-0.43%
)
Dow Jones
39,118.86
(
-0.12%
)
Brent Oil
84.85
(
0.00%
)
Bitcoin
61,430.82
(
0.89%
)
Post# of 252431
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

jbog

Send PM Follow Ignore
Followers 60
Posts 11519
Boards Moderated 0
Alias Born 07/16/2006

jbog

Member Level

Re: None

Monday, 03/04/2024 6:50:09 AM

Monday, March 04, 2024 6:50:09 AM

Post# of 252431
Revance announces $100M offering of common stock

06:41 RVNC Revance Therapeutics announced a proposed underwritten public offering of $100M of its common stock. The Company intends to use the net proceeds from the offering to advance the commercial growth of its aesthetics portfolio, including DAXXIFY and the RHA Collection of dermal fillers, support the launch of DAXXIFY into the therapeutics market, as well as for working capital, research and development and general corporate purposes. Barclays is acting as the sole book-running manager for the proposed offering.

Read more at:
https://thefly.com/n.php?id=3875378

Didn't someone say this would never happen?
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up